Crystal structure of 1,1 -(1,3-propanediyl)bis(4-cyano)pyridiniuiii dibromide, [NC-C5H4N-C3H6-NC5H4-CN]Br2

gan Inkmann E., Holzgrabe U., Schröder D., Reuter H.
Cyhoeddwyd 1997-12-01

New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics

gan Bulitta, J. B., Landersdorfer, C. B., Kinzig, M., Holzgrabe, U., Sorgel, F.
Cyhoeddwyd 2009

Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons

gan Hoellein L, Kaale E, Hebron Mwalwisi Y, Schulze MH, Vetye-Maler C, Holzgrabe U
Cyhoeddwyd 2022-04-01

Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers

gan Bulitta, J. B., Kinzig, M., Landersdorfer, C. B., Holzgrabe, U., Stephan, U., Sörgel, F.
Cyhoeddwyd 2011

Systematic Comparison of the Population Pharmacokinetics and Pharmacodynamics of Piperacillin in Cystic Fibrosis Patients and Healthy Volunteers

gan Bulitta, J. B., Duffull, S. B., Kinzig-Schippers, M., Holzgrabe, U., Stephan, U., Drusano, G. L., Sörgel, F.
Cyhoeddwyd 2007

Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers

gan Bulitta, J. B., Landersdorfer, C. B., Hüttner, S. J., Drusano, G. L., Kinzig, M., Holzgrabe, U., Stephan, U., Sörgel, F.
Cyhoeddwyd 2010

Agonists with supraphysiological efficacy at the muscarinic M(2) ACh receptor

gan Schrage, R, Seemann, WK, Klöckner, J, Dallanoce, C, Racké, K, Kostenis, E, De Amici, M, Holzgrabe, U, Mohr, K
Cyhoeddwyd 2013